Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
Am J Clin Pathol. 2013 Feb;139(2):231-41. doi: 10.1309/AJCP1T0JPBLSLAQF.
Clonal expansions of large granular lymphocytes (LGLs) have been identified in patients following stem cell transplants and may represent posttransplant LGL leukemias or reactive immune responses. To differentiate between these 2 possibilities, we assessed peripheral blood and bone marrow of patients with myeloma after autologous stem cell transplant. All patients examined shortly after autologous stem cell transplant had significant increases in the LGLs in the peripheral blood and bone marrow (71% of lymphocytes) as compared with controls (39%). This increase was detectable years after transplant. The LGLs had a reproducible immunophenotype of CD8+CD57+ T cells without phenotypic abnormalities in 19 of 20 patients. Sixty-five percent of the post-autologous stem cell transplant patients had clonal T-cell receptor gene rearrangements in the bone marrow, yet no patients had neutropenia or splenomegaly. Although the LGL expansions were clonal and persistent, the lack of clinical sequelae suggests the clonal LGL expansion is a reactive, potentially beneficial, immune response to autologous stem cell transplant.
大颗粒淋巴细胞 (LGL) 的克隆扩增已在干细胞移植后的患者中被发现,可能代表移植后 LGL 白血病或反应性免疫应答。为了区分这两种可能性,我们评估了自体干细胞移植后骨髓瘤患者的外周血和骨髓。与对照组(39%)相比,所有接受检查的患者在自体干细胞移植后不久,外周血和骨髓中的 LGL 均显著增加(占淋巴细胞的 71%)。这种增加在移植多年后仍可检测到。19/20 例患者的 LGL 具有可重现的免疫表型,为 CD8+CD57+T 细胞,无表型异常。65%的自体干细胞移植后患者的骨髓中存在克隆性 T 细胞受体基因重排,但无中性粒细胞减少或脾肿大。尽管 LGL 扩增是克隆性和持续性的,但缺乏临床后遗症表明克隆性 LGL 扩增是对自体干细胞移植的反应性、潜在有益的免疫应答。